Clinical and epidemiologic research has focused on the identification of risk factors that may
be modified in predementia syndromes, at a preclinical and early clinical stage of …

Preventing or postponing the onset of Alzheimer’s disease (AD) and delaying or slowing its
progression would lead to a consequent improvement of health status and quality of life in …

A growing body of epidemiological evidence suggested that metabolic syndrome (MetS) and
Mets components (impaired glucose tolerance, abdominal or central obesity, hypertension, …

The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed
susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we conducted a …

We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…

Apolipoprotein E (APOE) dependent lifetime risks (LTRs) for Alzheimer Disease (AD) are
currently not accurately known and odds ratios alone are insufficient to assess these risks. We …

Our objective was to construct and validate a Multidimensional Prognostic Index (MPI) for 1-year
mortality from a Comprehensive Geriatric Assessment (CGA) routinely carried out in …

In the last decade, the association between diet and cognitive function or dementia has
been largely investigated. In the present article, we systematically reviewed observational …

Background: Drug use increases with advancing age, and in older patients it is associated
with an increase in adverse drug reactions (ADRs). ADRs are a primary cause of morbidity …

Frailty, a critical intermediate status of the aging process that is at increased risk for negative
health-related events, includes physical, cognitive, and psychosocial domains or …